{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:23:02Z","timestamp":1775168582924,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1868,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1111\/j.1540-8159.2010.02843.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T19:00:19Z","timestamp":1279738819000},"page":"1342-1346","source":"Crossref","is-referenced-by-count":32,"title":["Defibrillation Threshold Testing in Patients with Hypertrophic Cardiomyopathy"],"prefix":"10.1111","volume":"33","author":[{"given":"BRETT D.","family":"ROBERTS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROBERT E.","family":"HOOD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAGDI M.","family":"SABA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TIMM M.","family":"DICKFELD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANASTASIOS P.","family":"SALIARIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEPHEN R.","family":"SHOROFSKY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,7,21]]},"reference":[{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eun027","article-title":"High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems","volume":"10","author":"Day","year":"2008","journal-title":"Europace"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1540-8167.2006.00345.x","article-title":"Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy","volume":"17","author":"Schuger","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.hrthm.2005.01.015","article-title":"Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion?","volume":"2","author":"Russo","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.86.4.1206","article-title":"Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study","volume":"86","author":"Epstein","year":"1992","journal-title":"Circulation"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0002-9149(97)00210-5","article-title":"Clinical predictors of transvenous biphasic defibrillation thresholds","volume":"79","author":"Gold","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1067\/mhl.2000.109388","article-title":"High defibrillation threshold at cardioverter defibrillator implantation under amiodarone treatment: Favorable effects of D, L-sotalol","volume":"29","author":"Boriani","year":"2000","journal-title":"Heart Lung"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0002-9149(96)00702-3","article-title":"Clinical predictors of transvenous defibrillation energy requirements","volume":"79","author":"Khalighi","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB9|cit9","first-page":"317","article-title":"Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators","volume":"62","author":"Lubinski","year":"2005","journal-title":"Kardiol Pol"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1460-9592.2003.00148.x","article-title":"High defibrillation thresholds in transvenous biphasic implantable defibrillators: Clinical predictors and prognostic implications","volume":"26","author":"Shukla","year":"2003","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0002-8703(91)90763-8","article-title":"Patients with a high defibrillation threshold: Clinical characteristics, management, and outcome","volume":"122","author":"Pinski","year":"1991","journal-title":"Am Heart J"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0167-5273(02)00036-0","article-title":"Hypertrophic cardiomyopathy with massive hypertrophy, amiodarone treatment and high defibrillation threshold at cardioverter-defibrillator implant","volume":"83","author":"Boriani","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2008.04.014","article-title":"ACC\/AHA\/HRS 2008 Guidelines for Device-based Therapy of Cardiac Rhythm Abnormalities","volume":"5","author":"Epstein","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ahj.2006.06.025","article-title":"Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation","volume":"152","author":"Leong-Sit","year":"2006","journal-title":"Am Heart J"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1540-8159.2004.00413.x","article-title":"Comparison of step-down and binary search algorithms for determination of defibrillation threshold in humans","volume":"27","author":"Shorofsky","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.hrthm.2007.11.018","article-title":"Complications associated with defibrillation threshold testing: The Canadian experience","volume":"5","author":"Birnie","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/01.CCM.0000261882.47616.7D","article-title":"Is all ventricular fibrillation the same? A comparison of is chemically induced with electrically induced ventricular fibrillation in a porcine cardiac arrest and resuscitation model","volume":"35","author":"Niemann","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/europace\/eum194","article-title":"Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation","volume":"9","author":"Lever","year":"2007","journal-title":"Europace"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/07853890252953527","article-title":"Differences in the activation patterns between sustained and self-terminating episodes of human ventricular fibrillation","volume":"34","author":"Makikallio","year":"2002","journal-title":"Ann Med"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1540-8159.2009.02329.x","article-title":"Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up","volume":"32","author":"Bianchi","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jacc.2008.04.051","article-title":"No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)","volume":"52","author":"Blatt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1253\/circj.CJ-08-0744","article-title":"QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy","volume":"73","author":"Nagai","year":"2009","journal-title":"Circ J"},{"key":"10.1111\/j.1540-8159.2010.02843.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/0735-1097(93)90379-F","article-title":"Predictors of defibrillation efficacy in patients undergoing epicardial defibrillator implantation. The Multicenter Pacemaker-Cardioverter-Defibrillator (PCD) Investigators Group","volume":"21","author":"Leitch","year":"1993","journal-title":"J Am Coll Cardiol"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.2010.02843.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1540-8159.2010.02843.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T05:13:05Z","timestamp":1625548385000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.2010.02843.x"}},"subtitle":["DFTS IN HCM"],"short-title":[],"issued":{"date-parts":[[2010,7,21]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.2010.02843.x","relation":{},"ISSN":["0147-8389"],"issn-type":[{"value":"0147-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7,21]]}}}